What does Baotou Dongbao Bio-Tech Co.,Ltd do?

Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 300239.SZ's market cap?

Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) has a market capitalization of approximately $3.07 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 300239.SZ pay a dividend?

Yes — Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) pays a dividend annually, with a trailing-twelve-month yield of 0.23%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

300239.SZ

Baotou Dongbao Bio-Tech Co.,Ltd

SHZ·Drug Manufacturers, Specialty & Generic · Healthcare

¥5.17¥0.02−0.39%

Market cap¥3.07B·Market closed·Aug 26 7:04 AM UTC

Price Chart

¥5.17−¥0.02 (−0.39%)today

−22.84%CAGR −5.05%

Select date range

FromTo

Jul 6, 2011Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.23%

Annual Dividend (FWD)¥0.01

Dividend Growth (5Y)−16.7%

Dividend Safety—

Payout Ratio12.8%

FCF Payout Ratio15.7%

Most Recent Dividend¥0.012

Ex-Dividend DateMay 27

Payment DateMay 27

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)−26.7%

EPS Growth (3Y)−23.0%

EPS Growth (5Y)+18.9%

Next Earnings DateMay 14

Last Report DateApr 23

Reported vs Estimate¥0.03

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥747.80M

Net Income¥54.99M

Net Margin7.4%

Operating Cash Flow¥161.45M

Capital Expenditures¥116.98M

Free Cash Flow¥44.48M

Return on Equity3.2%

Return on Invested Capital0.8%

Net Debt¥149.70M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 300239.SZ and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 300239.SZ's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 300239.SZ and 80,000+ other tickers.

About Baotou Dongbao Bio-Tech Co.,Ltd

Baotou Dongbao Bio-Tech Co., Ltd. specializes in the research, manufacturing, and global sales of gelatin and collagen products, serving both domestic and international markets. Their offerings include gelatin for food additives and pharmaceutical applications, as well as collagen peptides. The company was founded in 1997 and is headquartered in Baotou, People's Republic of China.

CEO: Fang Liu
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: SHZ
Employees: 1,424
Website: www.dongbaoshengwu.com

Peers

Peers Tab

603079.SS

Zhejiang Shengda Bio-Pharm Co., Ltd.

Cap

¥2.7B

300636.SZ

Jiangxi Synergy Pharmaceutical Co., Ltd.

Cap

¥2.9B

002864.SZ

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd

Cap

¥3.1B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 300239.SZ

What does Baotou Dongbao Bio-Tech Co.,Ltd do?: Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 300239.SZ's market cap?: Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) has a market capitalization of approximately $3.07 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 300239.SZ pay a dividend?: Yes — Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ) pays a dividend annually, with a trailing-twelve-month yield of 0.23%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.